Work

Multicenter Open-Label Phase 2 Study of Ibrutinib in Chronic Graft Versus Host Disease (cGVHD) after Failure of Corticosteroids

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.lba-3.lba-3

Authors: David Miklos, Corey S. Cutler, Mukta Arora, Edmund K. Waller, Madan Jagasia, Iskra Pusic, Mary E. Flowers, Aaron C. Logan, Ryotaro Nakamura, Bruce R. Blazar, Yunfeng Li, Indu Lal, Jason Dubovsky, Danelle F. James, Lori Styles, Samantha Jaglowski

Institutions: Stanford University, Dana-Farber Cancer Institute, University of Minnesota, Winship Cancer Institute, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Washington University in St. Louis, Fred Hutch Cancer Center, University of California, San Francisco, City Of Hope National Medical Center, City of Hope, Pharmacyclics (United States), The Ohio State University

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587411896

FWCI: 4.221

Cites:

Cited by: 16

Related to: 10